- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Companies
Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
25
0 new
Companies with a Value score of at least 3, ordered by Value score
25 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
6472 | NT$737.00 | -1.9% | 14.8% | NT$76.2b | NT$977.83 | PE19.5x | E16.2% | 1.6% | ||
1795 | NT$260.50 | -0.2% | -2.4% | NT$69.1b | NT$398.80 | PE15.9x | E22.3% | 1.8% | ||
1783 | NT$46.90 | -2.1% | -2.2% | NT$4.2b | n/a | PE26.9x | n/a | 2.1% | ||
4114 | NT$33.30 | 0.9% | -6.4% | NT$14.0b | NT$36.00 | PE19.5x | S12.7% | 1.6% | ||
6986 | NT$76.50 | -0.3% | 29.9% | NT$3.5b | n/a | PE28.3x | n/a | n/a | ||
1720 | NT$61.10 | -3.0% | -6.1% | NT$10.9b | n/a | PE12.9x | n/a | 4.4% | ||
6547 | NT$35.15 | 2.3% | -49.4% | NT$11.6b | NT$102.00 | PS17.8x | E198.9% | n/a | ||
8432 | NT$61.00 | -2.7% | 23.4% | NT$2.3b | n/a | PE19.6x | n/a | 2.1% | ||
3705 | NT$53.90 | -0.6% | 16.8% | NT$14.4b | n/a | PE13.9x | n/a | 4.3% | ||
6817 | NT$90.10 | -2.0% | -9.2% | NT$1.7b | n/a | PE11.1x | n/a | 7.3% | ||
6848 | NT$18.70 | 3.6% | 16.1% | NT$242.6m | n/a | PE14.1x | n/a | 6.0% | ||
1701 | NT$21.15 | 0% | -8.8% | NT$6.0b | n/a | PE16.2x | n/a | n/a | ||
1780 | NT$16.85 | -0.9% | 2.1% | NT$1.6b | n/a | PE15.3x | n/a | 5.0% | ||
1734 | NT$29.60 | 1.4% | -5.6% | NT$5.4b | n/a | PE16.1x | n/a | 3.1% | ||
4746 | NT$70.20 | -1.5% | -26.3% | NT$8.4b | NT$117.50 | PE21.5x | S7.8% | 2.8% | ||
4102 | NT$30.10 | -0.5% | -19.7% | NT$1.3b | n/a | PE14.7x | n/a | 2.7% | ||
6620 | NT$54.50 | 5.0% | -72.2% | NT$7.7b | NT$200.00 | PE17x | n/a | 1.8% | ||
3716 | NT$35.60 | -3.8% | n/a | NT$5.3b | n/a | PE14.2x | n/a | 0% | ||
4162 | NT$86.20 | -2.9% | -15.1% | NT$12.4b | NT$120.00 | PE33.5x | E-26.3% | 1.7% | ||
6785 | NT$137.00 | -6.2% | -34.4% | NT$9.2b | NT$290.00 | PE22.8x | S-133.2% | 1.1% | ||
6919 | NT$603.00 | 6.5% | 207.7% | NT$92.5b | NT$707.50 | PS1851.3x | E126.6% | n/a | ||
4160 | NT$69.30 | -10.0% | 83.9% | NT$1.8b | n/a | PE31.6x | n/a | 0.7% | ||
6446 | NT$566.00 | -3.2% | 69.5% | NT$188.1b | NT$853.50 | PE101.9x | E92.0% | n/a | ||
6539 | NT$65.10 | -2.0% | -53.7% | NT$1.3b | n/a | PE25.5x | n/a | 3.1% |